itraconazole and Myelodysplastic Syndromes

itraconazole has been researched along with Myelodysplastic Syndromes in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.00)18.7374
1990's2 (8.00)18.2507
2000's11 (44.00)29.6817
2010's11 (44.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aragón, B; Cámara, R; Gozalbo, I; Grau, S; Jurado, M; Sanz, J1
Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M1
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A1
Åkerborg, Ö; Björkholm, M; Höglund, M; Lundberg, J1
Chan, TS; Gill, H; Hwang, YY; Kwong, YL; Marcella, SW1
Eto, T; Henzan, H; Jinnochi, F; Jiromaru, T; Kawano, I; Matsumoto, K; Morita, K; Saito, N; Sakamoto, K; Semba, Y; Sugio, T; Takase, K; Yoshida, S1
Karthaus, M1
Jansen, JP; Janssen, JJ; Lugtenburg, E; O'Sullivan, AK; Rijnders, B; Span, LF; Stam, WB1
Alvarado, G; Blamble, D; Cortes, J; Faderl, S; Hernandez, M; Kantarjian, H; Koller, C; Mattiuzzi, GN; Pierce, S; Verstovsek, S; Xiao, L1
Aisa, Y; Kato, J; Mori, T; Nakamura, Y; Okamoto, S; Shimizu, T1
Lazzaro, C1
Dranitsaris, G; Khoury, H1
Ananda-Rajah, MR; Bajel, A; Cheng, A; Downey, MT; Grigg, A; Slavin, MA; Spelman, T; Thursky, KT; Vincent, J1
Beran, M; Cortes, J; Estey, E; Giles, F; Kantarjian, H; Koller, C; Kontoyiannis, D; Mattiuzzi, GN; Munsell, M; Raad, I; Shen, Y1
Bekele, BN; Cortes, J; Estey, E; Faderl, S; Giles, F; Kantarjian, H; Kontoyiannis, DP; Leitz, GJ; Lim, J; Mattiuzzi, GN; O'Brien, S; Pierce, S; Raad, I; Zhou, X1
Eisen, DP; Robson, J1
Abidi, MH; Dieterle, N; Garnick, JJ; Ibrahim, RB; Peres, E; Said, A1
Nakagawa, Y1
Angulo-Gonzalez, D; Cornely, OA; Goh, YT; Hardalo, C; Helfgott, D; Holowiecki, J; Maertens, J; Perfect, J; Petrini, M; Stockelberg, D; Suresh, R; Ullmann, AJ; Walsh, TJ; Winston, DJ1
Aoyama, Y; Ito, Y; Kanamaru, A; Kiguchi, T; Masaoka, T; Matsuda, M; Matsuura, Y; Mugitani, A; Ohyashiki, K; Sakamoto, E; Takeuchi, M; Tamura, K; Urabe, A; Wakita, H; Yoshida, I1
van Dissel, JT; van Nieuwkoop, C1
Almyroudis, NG; Gonzalez, AV; Segal, BH; Ullmann, AJ1
Confalonieri, F; Cruccu, V; Pedretti, D1
Blume, KG; Denning, DW; Stepan, DE; Stevens, DA1
Engelhard, D; Leibovici, V; Naparstek, E; Or, R1

Reviews

1 review(s) available for itraconazole and Myelodysplastic Syndromes

ArticleYear
Broad-spectrum antifungal prophylaxis in patients with cancer at high risk for invasive mold infections: point.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2008, Volume: 6, Issue:2

    Topics: Antifungal Agents; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Mycoses; Myelodysplastic Syndromes; Neoplasms; Neutropenia; Risk Assessment; Triazoles

2008

Trials

5 trial(s) available for itraconazole and Myelodysplastic Syndromes

ArticleYear
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Bilirubin; Drug Monitoring; Female; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2011
[Economic evaluation of posaconazole in prophylaxis of invasive fungal infections in Italian neutropenic patients with acute myeloid leukaemia or myelodysplastic syndrome].
    Le infezioni in medicina, 2010, Volume: 18, Issue:2

    Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysis; Deoxycholic Acid; Drug Combinations; Drug Costs; Equipment and Supplies; Fluconazole; Follow-Up Studies; Hospital Costs; Humans; Immunocompromised Host; Infusions, Intravenous; Italy; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Neutropenia; Oncology Nursing; Treatment Outcome; Triazoles

2010
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Cancer, 2003, Jan-15, Volume: 97, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Liposomes; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Prospective Studies; Survival Analysis

2003
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    The New England journal of medicine, 2007, Jan-25, Volume: 356, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fluconazole; Humans; Itraconazole; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Opportunistic Infections; Single-Blind Method; Treatment Outcome; Triazoles

2007
The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
    International journal of hematology, 2007, Volume: 85, Issue:2

    Topics: Adolescent; Adult; Aged; Antifungal Agents; Capsules; Female; Fluconazole; Humans; Itraconazole; Japan; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes

2007

Other Studies

19 other study(ies) available for itraconazole and Myelodysplastic Syndromes

ArticleYear
Cost-Effectiveness of Posaconazole Tablets for Invasive Fungal Infections Prevention in Acute Myelogenous Leukemia or Myelodysplastic Syndrome Patients in Spain.
    Advances in therapy, 2017, Volume: 34, Issue:9

    Topics: Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Female; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Economic; Myelodysplastic Syndromes; Solutions; Spain; Tablets; Triazoles

2017
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
    Mycoses, 2018, Volume: 61, Issue:3

    Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles

2018
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24 Suppl 1

    Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole

2018
Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
    Clinical drug investigation, 2014, Volume: 34, Issue:7

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Life Expectancy; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Neutropenia; Quality of Life; Quality-Adjusted Life Years; Sweden; Triazoles

2014
Posaconazole vs fluconazole or itraconazole for prevention of invasive fungal diseases in patients with acute myeloid leukemia or myelodysplastic syndrome: a cost-effectiveness analysis in an Asian teaching hospital.
    Journal of medical economics, 2016, Volume: 19, Issue:1

    Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hong Kong; Hospitals, Teaching; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Socioeconomic Factors; Triazoles

2016
Significance of monitoring trough plasma concentration levels for invasive fungal infection prophylaxis with itraconazole oral solution in patients with hematological malignancies: a prospective study.
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2016, Volume: 57, Issue:12

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Fungi; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Myelodysplastic Syndromes; Prospective Studies; Young Adult

2016
Treatment of aspergillosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Aug-01, Volume: 47, Issue:3

    Topics: Antifungal Agents; Aspergillosis; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neutropenia; Triazoles

2008
Economic evaluation of posaconazole vs. standard azole prophylaxis in high risk neutropenic patients in the Netherlands.
    European journal of haematology, 2008, Volume: 81, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Costs and Cost Analysis; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Models, Econometric; Mycoses; Myelodysplastic Syndromes; Netherlands; Neutropenia; Randomized Controlled Trials as Topic; Triazoles

2008
Overcoming the effect of rifampin on the tacrolimus metabolism by itraconazole administration in an allogeneic hematopoietic stem cell transplant recipient.
    International journal of hematology, 2010, Volume: 91, Issue:3

    Topics: Antibiotics, Antitubercular; Antifungal Agents; Drug Interactions; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Middle Aged; Myelodysplastic Syndromes; Rifampin; Tacrolimus; Transplantation, Homologous

2010
Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2011, Volume: 19, Issue:11

    Topics: Antifungal Agents; Antineoplastic Agents; Canada; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Models, Economic; Mycoses; Myelodysplastic Syndromes; Neoplasms; Randomized Controlled Trials as Topic; Triazoles

2011
Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period.
    Haematologica, 2012, Volume: 97, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Male; Medication Adherence; Middle Aged; Mycoses; Myelodysplastic Syndromes; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult

2012
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy.
    Cancer, 2004, Feb-01, Volume: 100, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fungemia; Humans; Infusions, Intravenous; Itraconazole; Leukemia, Myeloid, Acute; Logistic Models; Male; Middle Aged; Multivariate Analysis; Myelodysplastic Syndromes; Primary Prevention; Probability; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Risk Assessment; Survival Analysis; Treatment Outcome

2004
Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis.
    Mycoses, 2004, Volume: 47, Issue:3-4

    Topics: Aged; Antifungal Agents; Biopsy; Humans; Itraconazole; Lung; Lung Diseases, Fungal; Male; Myelodysplastic Syndromes; Rhizopus; Thrombocytosis; Zygomycosis

2004
Sirolimus-itraconazole interaction in a hematopoietic stem cell transplant recipient.
    Pharmacotherapy, 2006, Volume: 26, Issue:2

    Topics: Adenoviridae Infections; Adult; Anemia, Aplastic; Antifungal Agents; Bone Marrow Transplantation; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fatal Outcome; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Itraconazole; Male; Myelodysplastic Syndromes; Sirolimus

2006
[Prophylactic administration of fluconazole and itraconazole in febrile neutropenia associated with hematopoietic malignancy].
    The Japanese journal of antibiotics, 2006, Volume: 59, Issue:5

    Topics: Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neutropenia; Retrospective Studies

2006
Posaconazole prophylaxis in hematologic cancer.
    The New England journal of medicine, 2007, May-24, Volume: 356, Issue:21

    Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Leukemia, Myeloid, Acute; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Research Design; Triazoles

2007
[A case of pulmonary aspergillosis effectively treated with itraconazole. Possible interaction of the antimycotic agent with hydroquinidine].
    La Clinica terapeutica, 1995, Volume: 146, Issue:5

    Topics: Anti-Arrhythmia Agents; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Bradycardia; Drug Interactions; Electrocardiography; Itraconazole; Myelodysplastic Syndromes; Neutropenia; Quinidine; Radiography, Thoracic

1995
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
    The Journal of infection, 1992, Volume: 24, Issue:1

    Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female; Graft vs Host Disease; Hepatitis B; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Myelodysplastic Syndromes

1992
Treatment with itraconazole of widespread tinea corporis due to Trichophyton rubrum in a bone marrow transplant recipient.
    Bone marrow transplantation, 1988, Volume: 3, Issue:5

    Topics: Adult; Bone Marrow Transplantation; Drug Tolerance; Female; Humans; Itraconazole; Ketoconazole; Myelodysplastic Syndromes; Tinea

1988